Tadawul
·
Healthcare
·
Pharmaceuticals
·
Last Close
$36.80
▲ +0.00%
Key Metrics
P/E Ratio
16.12
FWD: 14.56
Market Cap
$2.94B
Mid Cap
Div Yield
2.53%
Annual dividend
EPS Growth
+11.52%
YoY
RSI (14)
76.73
Momentum
Beta
1.20
vs Market
52W High
$41.78
12.00% below
52W Low
$32.05
14.73% above
Volume
28.33K
Avg 73.16K
P/B
3.83
Price-to-book
ROE
24.31%
Return on equity
Free Float
52.86%
Public shares
Historical Returns
5D
+0.44%
1M
+6.56%
3M
+3.68%
6M
-0.65%
YTD
-2.54%
1Y
-7.44%
3Y
+54.38%
5Y
+201.86%
Financials & Valuation
TTM · Annual
| Total Revenue | $818.71M |
| Net Income | $177.72M |
| Revenue Growth (YoY) | +8.50% |
| Gross Margin | 46.05% |
| Operating Margin | 22.62% |
| Net Profit Margin | 21.71% |
| ROE | 24.31% |
| ROA · ROIC | 16.47% · 22.98% |
| P/E Ratio | 16.12 |
| Forward P/E (FY1) | 14.56 |
| PEG Ratio | 0.73 |
| P/S | 3.69 |
| P/B | 3.83 |
| P/FCF | 17.94 |
| EPS Growth | +11.52% |
| Outstanding Shares | 80.00M |
Technical Indicators
| 50-Day SMA | $35.02 |
| 200-Day SMA | $36.87 |
| RSI (14) | 76.73 |
| Beta | 1.20 |
| 52-Week High | $41.78 |
| 52-Week Low | $32.05 |
| Volume Today | 28.33K |
| Avg Daily Volume (30D) | 73.16K |
| Relative Volume | 0.39x |
| Volatility (10D) | 31.16 |
| Volatility (30D) | 28.39 |
| Free Float | 52.86% |
